Skip to content

Screener

Eligibility screening

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Sponsored by Iambic Therapeutics, IncStudy detailsClinicalTrials.gov

29 US sites in CA, CO, FL, IL +14

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.